Alex Kim
Analyst
Zelman & Associates
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-04-04–present
-
TriSalus Life Sciences, Inc. (TLSI)
Source not stated
Current -
Current
-
Zelman & Associates
Analyst
Transcript header (unverified)
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Company
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Standard Biotools Inc. (LAB) | Chief Financial Officer | $496,724 | $4,005,165 |
| 2024 | Standard Biotools Inc. (LAB) | Chief Financial Officer | $485,000 | $3,090,340 |
| 2023 | Standard Biotools Inc. (LAB) | Chief Financial Officer | $430,000 | $909,788 |
| 2022 | Standard Biotools Inc. (LAB) | Chief Financial Officer | $298,485 | $5,856,938 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.
-
-
-
-
-
-
-
Earnings call
Avalonbay Communities Inc Q4 FY2025 Earnings Call
-
-
-
-
-